Joanna Horobin
CIK 1560959 · Chief Medical Officer · last filed 2026-06-18
Joanna Horobin is a Chief Medical Officer who has filed 38 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for LQDA, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$408.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.65M
5
38
-$408.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 39,637 | $66.91 | $2.65M | -$135.8K | 8 | 2026-06-18 |
| KYMR | Director | 0 | $119.05 | $0 | -$280.4K | 5 | 2024-06-07 |
| Vyant Bio, Inc. (VYNT) Delisted | Director | 23,123 | $0.19 | $4.5K | $0 | 7 | 2023-01-19 |
| Aceragen, Inc. (IDRA) Delisted | Chief Medical Officer | 1,185 | $7.22 | $8.6K | $1.0K | 7 | 2019-07-11 |
| VSTM | Chief Medical Officer | 62 | $7.61 | $472 | $6.5K | 4 | 2015-01-12 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | LQDA | Grant (A) | +5,882 | $0 | EDGAR |
| 2025-08-21 | LQDA | Sell (S) | −5,000 | -$135.8K | EDGAR |
| 2025-08-19 | LQDA | Notice (144) | −5,000 | -$135.8K | EDGAR |
| 2025-06-20 | LQDA | Grant (A) | +18,396 | $0 | EDGAR |
| 2024-08-26 | KYMR | Notice (144) | −12,000 | -$589.9K | EDGAR |
| 2024-07-25 | KYMR | Notice (144) | −66,958 | -$2.95M | EDGAR |
| 2024-07-23 | KYMR | Notice (144) | −15,000 | -$652.2K | EDGAR |
| 2024-06-24 | LQDA | Grant (A) | +20,359 | $0 | EDGAR |
| 2024-06-07 | KYMR | Notice (144) | −8,500 | -$279.4K | EDGAR |
| 2024-06-07 | KYMR | Mixed | — | -$262.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.